At this year?s World Pork Expo, Merck Animal Health announced a new addition to its swine health product portfolio. CIRCUMVENT CML is the first and only combination vaccine shown to be effective for the vaccination of healthy swine three weeks or older against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis. Dr. Brett O?Brien, swine technical services manager, said the product will help producers maximize time and labor efficiency while protecting herd health.
Dr. O?Brien said that the vaccine offers the same amount of protection more efficiently, which will cut down on vaccination costs.
Vaccinating pigs can be a stressful and labor-intensive task, but Dr. O?Brien said this vaccine will make things easier on both the producers and the pigs.
Not only does the vaccine lower input costs, but it also increases production efficiency in the pigs by preventing infections in the first place.
For more information, visit drivenbyprevention.com.
